A detailed history of Susquehanna International Group, LLP transactions in Outset Medical, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 288,549 shares of OM stock, worth $176,014. This represents 0.0% of its overall portfolio holdings.

Number of Shares
288,549
Previous 32,009 801.46%
Holding current value
$176,014
Previous $71,000 1463.38%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$1.94 - $4.61 $497,687 - $1.18 Million
256,540 Added 801.46%
288,549 $1.11 Million
Q1 2024

May 07, 2024

SELL
$1.99 - $5.64 $268,096 - $759,832
-134,722 Reduced 80.8%
32,009 $71,000
Q4 2023

Feb 14, 2024

BUY
$3.07 - $10.25 $388,533 - $1.3 Million
126,558 Added 315.03%
166,731 $902,000
Q3 2023

Nov 14, 2023

SELL
$10.52 - $20.68 $230,388 - $452,892
-21,900 Reduced 35.28%
40,173 $437,000
Q2 2023

Aug 11, 2023

SELL
$17.18 - $23.76 $127,613 - $176,489
-7,428 Reduced 10.69%
62,073 $1.36 Million
Q1 2023

May 16, 2023

BUY
$18.25 - $30.26 $1.27 Million - $2.1 Million
69,501 New
69,501 $1.28 Million
Q3 2022

Nov 14, 2022

BUY
$14.67 - $21.7 $214,182 - $316,820
14,600 New
14,600 $233,000
Q4 2021

Feb 14, 2022

BUY
$43.29 - $58.77 $257,402 - $349,446
5,946 Added 123.16%
10,774 $497,000
Q3 2021

Nov 15, 2021

SELL
$36.86 - $54.98 $646,340 - $964,074
-17,535 Reduced 78.41%
4,828 $239,000
Q2 2021

Aug 11, 2021

BUY
$41.49 - $59.92 $448,548 - $647,795
10,811 Added 93.59%
22,363 $1.12 Million
Q1 2021

May 17, 2021

BUY
$46.94 - $58.66 $542,250 - $677,640
11,552 New
11,552 $628,000
Q4 2020

Feb 16, 2021

SELL
$42.51 - $64.0 $296,677 - $446,656
-6,979 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$49.75 - $60.68 $347,205 - $423,485
6,979 New
6,979 $349,000

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $29.3M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.